Meningococcal Groups C and Y and Haemophilus b Tetanus Toxoid Conjugate Vaccine (HibMenCY-TT; MenHibrix®): A Review
出版年份 2013 全文链接
标题
Meningococcal Groups C and Y and Haemophilus b Tetanus Toxoid Conjugate Vaccine (HibMenCY-TT; MenHibrix®): A Review
作者
关键词
Conjugate Vaccine, Tetanus Toxoid, Capsular Polysaccharide, Meningococcal Disease, Primary Vaccination
出版物
DRUGS
Volume 73, Issue 7, Pages 703-713
出版商
Springer Nature
发表日期
2013-05-06
DOI
10.1007/s40265-013-0048-9
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Antibody Persistence for up to 5 Years After a Fourth Dose of Haemophilus influenzae Type b and Neisseria Meningitidis Serogroups C and Y–Tetanus Toxoid Conjugate Vaccine (HibMenCY-TT) Given at 12–15 Months of Age
- (2013) Gary S. Marshall et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Meningococcal Quadrivalent (Serogroups A, C, W135 and Y) Tetanus Toxoid Conjugate Vaccine (Nimenrix™)
- (2012) Jamie D. Croxtall et al. DRUGS
- Public health and economic benefits of new pediatric influenza vaccination programs in Argentina
- (2012) Norberto Giglio et al. Human Vaccines & Immunotherapeutics
- Immunogenicity and safety of measles-mumps-rubella and varicella vaccines coadministered with a fourth dose ofHaemophilus influenzaetype b andNeisseria meningitidisserogroups C and Y-tetanus toxoid conjugate vaccine in toddlers
- (2012) Kristina A. Bryant et al. Human Vaccines & Immunotherapeutics
- Haemophilus influenzaetype b–Neisseria meningitidisserogroups C and Y tetanus toxoid conjugate vaccine for infants and toddlers
- (2011) Kristina A Bryant et al. Expert Review of Vaccines
- Co-administration of a novelHaemophilus influenzaetype b andNeisseria meningitidisserogroups C and Y-tetanus toxoid conjugate vaccine does not interfere with the immune response to antigens contained in infant vaccines routinely used in the United States
- (2011) Gary S. Marshall et al. Human vaccines & immunotherapeutics
- Immunogenicity and Safety of H influenzae Type b-N meningitidis C/Y Conjugate Vaccine in Infants
- (2011) K. A. Bryant et al. PEDIATRICS
- The Global Meningococcal Initiative: Recommendations for reducing the global burden of meningococcal disease
- (2011) Lee H. Harrison et al. VACCINE
- Epidemiological Profile of Meningococcal Disease in the United States
- (2010) Lee H. Harrison CLINICAL INFECTIOUS DISEASES
- The epidemiology of meningococcal disease and the impact of vaccines
- (2010) Ameneh Khatami et al. Expert Review of Vaccines
- Meningococcal Disease: The Organism, Clinical Presentation, and Worldwide Epidemiology
- (2010) Jaffar A. Al‐Tawfiq et al. JOURNAL OF TRAVEL MEDICINE
- IMMUNE RESPONSE AND ONE-YEAR ANTIBODY PERSISTENCE AFTER A FOURTH DOSE OF A NOVEL HAEMOPHILUS INFLUENZAE TYPE B AND NEISSERIA MENINGITIDIS SEROGROUPS C AND Y-TETANUS TOXOID CONJUGATE VACCINE (HibMenCY) AT 12 TO 15 MONTHS OF AGE
- (2010) Gary S. Marshall et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Immunogenicity and Safety of an Investigational Combined Haemophilus influenzae Type B-Neisseria meningitidis Serogroups C and Y-Tetanus Toxoid Conjugate Vaccine
- (2010) Terry Nolan et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Quadrivalent meningococcal vaccines: Hyporesponsiveness as an important consideration when choosing between the use of conjugate vaccine or polysaccharide vaccine
- (2010) Michael Bröker et al. Travel Medicine and Infectious Disease
- Changes inNeisseria meningitidisDisease Epidemiology in the United States, 1998–2007: Implications for Prevention of Meningococcal Disease
- (2009) Amanda C. Cohn et al. CLINICAL INFECTIOUS DISEASES
- Randomized Trial to Assess Immunogenicity and Safety of Haemophilus influenzae Type b and Neisseria meningitidis Serogroups C and Y–Tetanus Toxoid Conjugate Vaccine in Infants
- (2009) Colin D. Marchant et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Global epidemiology of meningococcal disease
- (2009) Lee H. Harrison et al. VACCINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now